<DOC>
	<DOC>NCT00603473</DOC>
	<brief_summary>Examine the efficacy, safety and pharmacokinetics of gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures</brief_summary>
	<brief_title>A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Japanese male or females, ages 315 years old at acquisition of informed consent, 15 years old or less at the baseline visit Seizures are classified as simple partial, complex partial or partial becoming secondarily generalized (defined according to the International League Against Epilepsy) Have not been able to achieve adequate seizure control with antiepileptic drugs Seizures related to drugs or acute medical illness History of any serious medical or psychiatric disorder Diagnosis or history of a structural CNS lesion or an encephalopathy shown to be progressive</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>